How organoids can redefine pre-clinical research
Drug Target Review
SEPTEMBER 22, 2023
8 Furthermore, the absence of immune, mesenchymal, or endothelial cells limits the applicability of organoids for the assessment of certain therapies, such as immuno-oncology treatments or drug metabolism studies where more complex models are needed. Nat Rev Bioeng [Internet]. 2023 Jan 19;1(1):32–45. 95: 729–38
Let's personalize your content